These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15642203)

  • 41. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
    Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.
    Lei L; Wang XJ; Zheng ZG; Huang J; Cao WM; Chen ZH; Shao XY; Cai JF; Ye WW; Lu HY
    Anat Rec (Hoboken); 2011 Jun; 294(6):941-4. PubMed ID: 21548109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
    Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Fenollar F; Goncalves A; Esterni B; Azza S; Habib G; Borg JP; Raoult D
    J Infect Dis; 2006 Nov; 194(10):1356-66. PubMed ID: 17054064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology].
    Liu CB; Liang Y; Pan CQ; Zhang J
    Zhonghua Nan Ke Xue; 2009 Mar; 15(3):232-6. PubMed ID: 19452695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.
    Mendrinos S; Nolen JD; Styblo T; Carlson G; Pohl J; Lewis M; Ritchie J
    Cancer; 2005 Jun; 105(3):178-83. PubMed ID: 15822128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
    Liu DH; Zhang LM; Feng WY
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum proteomics profiling for diagnosis of myasthenia gravis].
    Wu GY; Pang JZ; Cheng C; Lu JJ; Ma J; Gu Y; Zhong FT; Luo HH
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(31):2184-7. PubMed ID: 20058595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
    Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
    Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.